KMS Medisurgi Ltd
₹ 126
0.00%
30 Mar
- close price
About
Incorporated in 2016, KMS Medisurgi Ltd operates in the manufacturing of Surgical Equipment.[1]
Key Points
- Market Cap ₹ 41.8 Cr.
- Current Price ₹ 126
- High / Low ₹ 132 / 120
- Stock P/E 70.8
- Book Value ₹ 25.2
- Dividend Yield 0.04 %
- ROCE 8.26 %
- ROE 5.59 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 160 to 111 days.
Cons
- Stock is trading at 5.02 times its book value
- The company has delivered a poor sales growth of 6.16% over past five years.
- Company has a low return on equity of 6.74% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.62 | 8.89 | 8.41 | 7.90 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | 12.74 | |
| 7.01 | 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 12.99 | 11.51 | |
| Operating Profit | 0.61 | 0.72 | 0.82 | 0.95 | 0.47 | 0.30 | 0.66 | 0.50 | 0.53 | 0.96 | 0.85 | 0.95 | 1.23 |
| OPM % | 8.01% | 8.10% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 6.81% | 9.65% |
| 0.05 | 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0.00 | 0.10 | 0.05 | 0.02 | 0.03 | 0.03 | 0.05 | |
| Interest | 0.23 | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.02 | 0.10 | 0.14 |
| Depreciation | 0.39 | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.27 | 0.33 |
| Profit before tax | 0.04 | 0.08 | 0.30 | 0.36 | 0.18 | 0.20 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | 0.61 | 0.81 |
| Tax % | 50.00% | 50.00% | 53.33% | 38.89% | 50.00% | 40.00% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | 27.87% | |
| 0.03 | 0.03 | 0.14 | 0.21 | 0.10 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | 0.59 | |
| EPS in Rs | 0.60 | 0.60 | 1.17 | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 | 1.79 |
| Dividend Payout % | 0.00% | 0.00% | 25.71% | 5.71% | 16.50% | 13.75% | 15.00% | 13.75% | 7.50% | 2.89% | 3.67% | 3.75% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 11% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 32% |
| 3 Years: | 26% |
| TTM: | 943% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | 15% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 1.20 | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves | 0.61 | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 | 5.02 |
| 3.99 | 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | 0.87 | |
| 1.91 | 3.21 | 2.60 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | 2.97 | |
| Total Liabilities | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 12.16 |
| 2.72 | 2.25 | 1.98 | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | 2.98 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 4.29 | 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 8.66 | 9.18 | |
| Total Assets | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 12.16 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 1.35 | -0.24 | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | |
| -1.82 | 0.05 | -0.03 | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.51 | -0.96 | |
| 1.87 | -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | |
| Net Cash Flow | 0.06 | -0.01 | 0.86 | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 |
| Free Cash Flow | -1.80 | 1.40 | -0.31 | -0.29 | -1.58 | 0.36 | -0.86 | 0.36 | -0.19 | -0.20 | 1.09 | 0.44 |
| CFO/OP | 3% | 188% | -18% | 106% | -309% | 250% | -129% | 108% | 0% | 59% | 173% | 96% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 143.22 | 128.10 | 163.19 | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 | 111.02 |
| Inventory Days | 23.34 | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | 45.45 | 42.45 | 70.96 | 87.18 | |
| Days Payable | 110.10 | 155.51 | 141.02 | 139.76 | 134.58 | 134.09 | 70.42 | 100.27 | 58.60 | 85.22 | 41.86 | |
| Cash Conversion Cycle | 56.46 | 22.61 | 39.94 | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 | 156.34 |
| Working Capital Days | 4.31 | 21.76 | 30.81 | 9.24 | 158.07 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 | 144.01 |
| ROCE % | 6.28% | 7.70% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% | 8.26% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Inventory of Raw Materials Rs. in Lakhs |
|
|||||||||
| Increase in Median Remuneration of Employees Percentage (%) |
||||||||||
| Number of Permanent Employees Number |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Non-Applicability Of Report On Corporate Governance Pursuant To Regulation 27 (2) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
13h - KMS Medisurgi says corporate governance report not applicable for FY ended 31 March 2026.
-
Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
13h - Company says related party transaction disclosure not applicable for FY2026 under SME platform exemption.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026; no dematerialisation requests received.
-
Closure of Trading Window
30 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for year/half-year ended 31 March 2026.
-
Non-Applicability Of Report On Corporate Governance Pursuant To Regulation 27 (2) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
14 Jan - KMS Medisurgi: BSE SME listing exempts company from corporate governance report for quarter ended 31 Dec 2025.
Business Overview:[1]
KMSML manufactures & undertakes job work of coating of various substrates like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with the adhesive. It is engaged in the business of ethical marketing and distribution of
Surgical Disposable, Haemostat, Medical
Devices, Urology Equipment, Surgery Equipment, Orthopedic /Physiotherapy Equipment, Blood Banking Equipment’s and other such Surgical Equipment in India.